Aptevo Therapeutics Files 8-K: Material Agreement
Ticker: APVO · Form: 8-K · Filed: Apr 4, 2025 · CIK: 1671584
| Field | Detail |
|---|---|
| Company | Aptevo Therapeutics Inc. (APVO) |
| Form Type | 8-K |
| Filed Date | Apr 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-k
Related Tickers: APVO
TL;DR
APVO filed an 8-K on 4/3/25 for a material definitive agreement.
AI Summary
On April 3, 2025, Aptevo Therapeutics Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial statements and exhibits. The company is incorporated in Delaware and headquartered in Seattle, Washington.
Why It Matters
This 8-K filing indicates a significant new agreement for Aptevo Therapeutics, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Numbers
- 001-37746 — SEC File Number (Identifies the company's filing history with the SEC.)
- 81-1567056 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Aptevo Therapeutics Inc. (company) — Registrant
- April 03, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Seattle, Washington (location) — Principal Executive Offices
- 206-838-0500 (phone_number) — Registrant's Telephone Number
FAQ
What is the nature of the material definitive agreement filed by Aptevo Therapeutics?
The 8-K filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 03, 2025.
Where is Aptevo Therapeutics Inc. headquartered?
Aptevo Therapeutics Inc.'s principal executive offices are located in Seattle, Washington.
What is the SEC file number for Aptevo Therapeutics Inc.?
The SEC file number for Aptevo Therapeutics Inc. is 001-37746.
What is the SIC code for Aptevo Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for Aptevo Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding Aptevo Therapeutics Inc. (APVO).